Professor Toth was a Postdoctoral Fellow at Carleton University, Ottawa Canada (1974-76, Prof J.W. ApSimon). He returned to Hungary to work as a Research Associate (1977-82), then Scientific Group Leader (1982-1987) at the Central Research Institute for Chemistry, Hungarian Academy of Science. Professor Toth joined the School of Pharmacy at the University of London in 1987 as a Senior Lecturer and Royal Society sponsored Senior Research Fellow. He became a Reader in Medicinal Organic Chemistry in 1994 before relocating to The University of Queensland in 1998. Professor Toth has since been appointed as a Fellow of both the Royal Australian Chemical Institute (2008) and the Queensland Academy of Arts and Sciences (2009). He has more than 300 publications and 43 patents.
Professor Toth’s major research interests are drug delivery, immunoadjuvants, carbohydrates, lipids, peptides, nucleosides and nucleotides. New developments in drug/vaccine delivery will clearly have a strong economic impact on the pharmaceutical and biotechnology industries. At the School of Pharmacy, University of London, and at The University of Queensland, Professor Toth has built up a strong, very productive research group (presently about 25 members), where the research orientation is well suited to the direction of modern multidisciplinary pharmaceutical sciences. Professor Toth also has a keen interest in research commercialisation. He is one of the founding members of Alchemia (listed on the Australian Stock Exchange), Implicit Biosciences Pty Ltd and Neurotide. Professor Toth is also a key partner in the Queensland Preclinical Drug Development Facility (TetraQ), established in 2005 as a world-class facility to provide integrated preclinical drug development services to Queensland and Australian biotechnology companies engaged in human therapeutics development. Professor Toth’s primary research goal is to develop versatile delivery mechanisms that can be adapted to suit a broad range of drug and vaccine candidates.
NHMRC Program Grant 2013-2017
Tropical Disease – Immunity, pathogenesis and vaccine development: global translation.
Total value of grant: $17, 100, 585
ARC Discovery Grant 2011-2015
Liposaccharide based peptide and vaccine delivery systems: improving the bioavailability and immunogenicity of LHRH.
Total value of grant: $1, 030, 000
NHMRC Program Grant 2004-2012
Tropical Infectious Diseases – Pathogenesis and vaccine research.
Total value of grant: $22, 000, 000
ARC Discovery Project Grant 2010-2012
Lipid and carbohydrate based systems to target and deliver peptide drug candidates to specific cells.
Total value of grant: $750, 000
Chemistry, medicinal chemistry and drug delivery.
Editor in Chief: Current Drug Delivery
Editor in Chief: Drug Delivery letters
Associate Editor: Medicinal Chemistry
Board Member: Mini Reviews in Medicinal Chemistry, Drug Design and Reviews Online
Scientific Advisory Board Member: Implicit Bioscience Pty Ltd.
Member ARC College of Experts 2008-2010
Business/Higher Education Round Table (BHERT) Award: Outstanding Achievement in International Collaborative R&D 2005
Adrian Albert Award RACI Biomolecular Chemistry Division